BANJUL, Gambia: A trial opened on Tuesday in The Gambia´s capital Banjul over the deaths of small children who took a cough syrup made by the India-based Maiden Pharmaceuticals.
Justice Ebrima Jaiteh of the High Court in Banjul adjourned the proceedings until November 7 after finding that three state defendants who had failed to appear “lacked diligence”.
Some 70 children aged 5 and under died in 2022 after taking the over-the-counter medicines, leading to a national outcry in the West African nation of about 2.5 million people.
Nineteen plaintiffs representing family members who were victims in July filed the suit, according to Salieu Taal, president of The Gambia Bar Association and one of the lawyers representing the plaintiffs.
The families are suing five defendants -- Maiden Pharmaceuticals, local distributor Atlantic Pharmaceuticals, the Medical Controls Agency (MCA), the Ministry of Health and Attorney General Dawda A. Jallow -- to demand they admit that the children were killed by consuming contaminated medicines.
They are also suing for an admission that the MCA failed in its statutory duty to regulate the quality and safety of medicines. The health ministry, MCA and attorney general requested a delay to the start of the trial, a motion the judge dimissed. He ordered the three to pay 10,000 Dalasis to the plaintiffs.
A Boeing plane seen in this image.— AFP/file BRASALIA: At least seven people were injured on Monday when an Air...
A display board at Munich’s main station informing passengers: ‘Onset of winter: rail transport in southern...
Mohamed Ould Cheikh El Ghazouani, president of Mauritania and leader of the Union for the Republic, waves to...
Police and rescuers stand next to a car involved in accident that resulted in several people killed and injured in...
People watch a TV broadcasting a news report on Russian President Vladimir Putin’s visit to North Korea, in Seoul,...
A firefighting helicopter flies over a firefighter and volunteers trying to extinguish a wildfire burning in Keratea,...